Although Trp metabolism by IL4I1 does not appear enhanced in high-grade serous ovarian cancer patients, this does not exclude an elevated metabolism of other substrates by IL4I1. This evidence concerns the gene IL4I1 and ovarian serous adenocarcinoma.